These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6888088)

  • 41. Cimetidine clearance in the obese.
    Bauer LA; Wareing-Tran C; Edwards WA; Raisys V; Ferreri L; Jack R; Dellinger EP; Simonowitz D
    Clin Pharmacol Ther; 1985 Apr; 37(4):425-30. PubMed ID: 3979004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.
    Ziemniak JA; Assael BM; Padoan R; Schentag JJ
    Eur J Clin Pharmacol; 1984; 26(2):183-9. PubMed ID: 6723756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of interaction between verapamil and cimetidine.
    Abernethy DR; Schwartz JB; Todd EL
    Clin Pharmacol Ther; 1985 Sep; 38(3):342-9. PubMed ID: 4028631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cimetidine on steady-state serum digoxin concentrations.
    Fraley DS; Britton HL; Schwinghammer TL; Kalla R
    Clin Pharm; 1983; 2(2):163-5. PubMed ID: 6883945
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetics of cimetidine after subchronic administration.
    Chin TW; Spino M; MacLeod SM; Mahon WA; Soldin SJ
    Eur J Clin Pharmacol; 1986; 30(6):741-4. PubMed ID: 3770069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.
    Larsson R; Erlanson P; Bodemar G; Norlander B; Fransson L; Strouth L
    Eur J Clin Pharmacol; 1982; 21(4):325-30. PubMed ID: 7056278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced cimetidine clearance with age.
    Gugler R; Somogyi A
    N Engl J Med; 1979 Aug; 301(8):435. PubMed ID: 460350
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of cimetidine in hospital patients.
    Hall KW; Behun M; Irvine-Meek J; Otten N
    Can Med Assoc J; 1981 Jun; 124(12):1579-85. PubMed ID: 7248867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The kinetics of oral cimetidine in children with cystic fibrosis.
    Bradbear RA; Shepherd RW; McGuffie C; Grice J; Roberts RK
    Br J Clin Pharmacol; 1981 Aug; 12(2):248-9. PubMed ID: 7306438
    [No Abstract]   [Full Text] [Related]  

  • 52. Age and renal clearance of cimetidine.
    Drayer DE; Romankiewicz J; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1982 Jan; 31(1):45-50. PubMed ID: 7053303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of the aldose reductase inhibitor tolrestat: studies in healthy young and elderly male and female subjects and in subjects with diabetes.
    Fruncillo R; Troy S; Parker V; Mayersohn M; Hicks D; Kraml M; Battle M; Chiang S
    Clin Pharmacol Ther; 1996 Jun; 59(6):603-12. PubMed ID: 8681485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of tacrine oral clearance by cimetidine.
    Forgue ST; Reece PA; Sedman AJ; deVries TM
    Clin Pharmacol Ther; 1996 Apr; 59(4):444-9. PubMed ID: 8612390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cimetidine impairs elimination of chlordiazepoxide (Librium) in man.
    Desmond PV; Patwardhan RV; Schenker S; Speeg KV
    Ann Intern Med; 1980 Aug; 93(2):266-8. PubMed ID: 7406377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral and intravenous disposition of cyclosporine in psoriatic patients.
    Galla F; Marzocchi V; Croattino L; Poz D; Baraldo M; Furlanut M
    Ther Drug Monit; 1995 Jun; 17(3):302-4. PubMed ID: 7624927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypothalamic-pituitary effects of cimetidine.
    Delitala G; Stubbs WA; Wass JA; Yeo T; Jones A; Williams S; Besser GM; La Brooy SJ; Misiewicz JJ
    Lancet; 1978 Nov; 2(8098):1054-5. PubMed ID: 82073
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

  • 59. Cimetidine and parenteral nutrition.
    Moore RA; Feldman S; Treuting J; Bloss R; Dudrick SJ
    JPEN J Parenter Enteral Nutr; 1981; 5(1):61-3. PubMed ID: 6785475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood level of cimetidine in relation to age.
    Redolfi A; Borgogelli E; Lodola E
    Eur J Clin Pharmacol; 1979 May; 15(4):257-61. PubMed ID: 477710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.